SLC5A2 and chronic kidney disease: When listing characteristics that would influence their decision to prescribe SGLT2 inhibitors to this group, participants included the following factors (not covered in the statements): heart failure (HF), CKD or renal function, risk factors, BP, weight, patient ability to understand risks and report issues, diabetes type, patient preference, current or previous infection, glycaemic control, DKA risk, pre‐conception, dietary habits, age and frailty.